Cigna expects revenue gains from launches of Humira biosimilars Ruchika Sharma7 Feb 2023 11:44 AM ISTCigna's PBM unit has both Humira and Amgen's Amjevita on its list of covered drugs.
AbbVie raises sales outlook of Skyrizi, Rinvoq to USD 17.5 billion in 2025 MD Bureau13 Jan 2023 2:26 PM ISTThe two drugs Skyrizi and Rinvoq are part of AbbVie's long term growth strategy to offset Humira's loss of exclusivity.
Sandoz, Teva Pharma plans to ramp up biosimilars production Ruchika Sharma23 Nov 2022 1:30 PM ISTTeva Chief Executive KÃ¥re Schultz said the company was targeting "80% of what's going off-patent in the next 10 years" including big sellers like the...
Sandoz Supplemental Biologics License application accepted by US FDA for biosimilar Hyrimoz high concentration formulation Ruchika Sharma24 July 2022 10:00 AM ISTAdalimumab is a human immunoglobulin G1 (IgG(1)) monoclonal antibody targeting tumor necrosis factor alpha (TNF-a).
Pfizer supplemental application for ABRILADA interchangeability accepted by USFDA for review MD Bureau27 Feb 2022 10:30 AM ISTNew Delhi: Pfizer Inc. has announced that the U.S. Food and Drug Administration (USFDA) has accepted for review the Prior Approval Supplement (PAS) to...
Boehringer Ingelheim Cyltezo gets USFDA nod as 1st iterchangeable biosimilar with Humira Ruchika Sharma17 Oct 2021 11:00 AM ISTRidgefield: Boehringer Ingelheim has recently announced that the U.S. Food and Drug Administration (USFDA) has approved the supplemental Biologics...
Intas secures CDSCO panel nod to study arthritis drug Adalimumab Medical Dialogues Team24 Sept 2021 5:08 PM ISTNew Delhi: In a significant development, drug firm Intas has got a green signal from the Subject Expert Committee (SEC) functional under the Central...
Sandoz launches biosimilar Hyrimoz in Canada Ruchika Sharma18 Feb 2021 12:33 PM ISTHyrimoz is a fully human tumor necrosis factor (TNF) blocker which helps to reduce inflammation.
Cadila Pharma launches arthritis biosimilar drug Cadalimab in India Ruchika Sharma29 Aug 2020 2:09 PM ISTCadalimab has shown to have significant reduction in signs and symptoms of Rheumatoid Arthritis, Juvenile Idiopathic Arthritis, Ankylosing...
